Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by GrahamBon Jul 10, 2023 2:51pm
107 Views
Post# 35534014

Sale of a machine

Sale of a machineLots of excitement and noise about a sale to a German hospital, including negative comments directed to those who have simply made a decision based on the facts to sit out and wait for confirmation of significant and sustained sales.
Good we are up after being down over 80% - Now only has to increase 150% to get back to 60 cents.

For those that have no interest in my comments, they sure seem to spend a lot of time bringing them out repeatedly, when I am not even here much anymore.

Ok since you do clearly do care, I will come back and give you my take.

Still waiting to see those sales and the amounts actually received, and the cash burn.
How much was actually recognized as revenue?
What is the cost of a sale compared to all the marketing and sales effort?

Still, good on the longs-glad to see the share price has come up for those that were down or those that speculated and bought.
 
So for those who are promoting validation of VPT based on a media  companies linked in post.
I do ask whether there is a link between VPT and Mullins, given the corporations stated goal:
 
As the only search firm in the world with a full media and marketing arm in our organization, we understand how critical it is to tell our clients stories at scale to support Attention & Awareness, M&A, Recruiting & Talent Access for emerging technology companies.
https://www.linkedin.com/company/the-mullings-group
 
I will wait to hear.
In the meantime pleased to wait, and see if there are any sustained sales given a cash burn of around 3 million/year-figured they need at least 50 units sold/year to be sustainable.
 Still, good to have 1 recognized(after all wasn’t it last supposed to be 30 by 2022 year end?)
 
Ok will be back when there is news, mostly financial data, or some particuarly egregious comments 
<< Previous
Bullboard Posts
Next >>